| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| PGRThe Progressive Corporation | 119.3B | 203.52 | 14.13 | 21.36% | 12.66% | 32% | 12.43% | 0.27 |
| ALLThe Allstate Corporation | 51.15B | 195.47 | 11.51 | 12.24% | 12.65% | 30.48% | 17.05% | 0.38 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.83B | 23.42B | 26.82B | 31.95B | 39B | 42.64B | 47.68B | 49.59B | 62.08B | 75.34B |
| Revenue Growth % | 0.08% | 0.12% | 0.15% | 0.19% | 0.22% | 0.09% | 0.12% | 0.04% | 0.25% | 0.21% |
| Medical Costs & Claims | 15.99B | 18.74B | 20.93B | 24.29B | 28.49B | 28.39B | 37.34B | 42.04B | 50.32B | 54.44B |
| Medical Cost Ratio % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 4.84B | 4.67B | 5.88B | 7.66B | 10.5B | 14.24B | 10.34B | 7.55B | 11.76B | 20.9B |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 0.06% | -0.03% | 0.26% | 0.3% | 0.37% | 0.36% | -0.27% | -0.27% | 0.56% | 0.78% |
| Operating Expenses | 2.93B | 3.2B | 3.74B | 4.5B | 5.34B | 7.07B | 6.13B | 6.63B | 6.86B | 10.19B |
| OpEx / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 150.5M | 199.5M | 236.1M | 262.4M | 306.1M | 331.8M | 337.4M | 306M | 285M | 284M |
| Combined Ratio % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 1.91B | 1.47B | 2.14B | 3.16B | 5.16B | 7.17B | 4.21B | 922M | 4.9B | 10.71B |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 0% | -0.23% | 0.45% | 0.48% | 0.63% | 0.39% | -0.41% | -0.78% | 4.32% | 1.18% |
| EBITDA | 2.06B | 1.67B | 2.38B | 3.43B | 5.47B | 7.5B | 4.55B | 1.23B | 5.19B | 11B |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 136M | 140.9M | 153.1M | 166.5M | 189.7M | 217M | 218.6M | 244M | 268M | 279M |
| Non-Operating Income | -136M | -140.9M | -153.1M | -166.5M | -189.7M | -217M | -218.6M | -244M | -268M | -279M |
| Pretax Income | 1.91B | 1.47B | 2.14B | 3.16B | 5.16B | 7.17B | 4.21B | 922M | 4.9B | 10.71B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 611.1M | 413.5M | 540.8M | 542.6M | 1.18B | 1.47B | 859.1M | 200M | 1B | 2.23B |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 1.27B | 1.03B | 1.59B | 2.62B | 3.97B | 5.7B | 3.35B | 722M | 3.9B | 8.48B |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -0.01% | -0.19% | 0.54% | 0.64% | 0.52% | 0.44% | -0.41% | -0.78% | 4.41% | 1.17% |
| EPS (Diluted) | 2.15 | 1.76 | 2.72 | 4.46 | 6.72 | 9.66 | 5.66 | 1.18 | 6.58 | 14.40 |
| EPS Growth % | 0% | -0.18% | 0.55% | 0.64% | 0.51% | 0.44% | -0.41% | -0.79% | 4.58% | 1.19% |
| EPS (Basic) | 2.16 | 1.77 | 2.74 | 4.49 | 6.75 | 9.71 | 5.69 | 1.19 | 6.61 | 14.45 |
| Diluted Shares Outstanding | 589.2M | 585M | 585.7M | 586.7M | 587.2M | 587.6M | 587.1M | 587.1M | 587.5M | 587.7M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 29.82B | 33.43B | 38.7B | 46.58B | 54.91B | 64.1B | 71.13B | 75.47B | 88.69B | 105.75B |
| Asset Growth % | 0.16% | 0.12% | 0.16% | 0.2% | 0.18% | 0.17% | 0.11% | 0.06% | 0.18% | 0.19% |
| Total Investment Assets | 0 | 0 | 0 | 0 | 0 | 0 | 96.33B | 103.06B | 128.17B | 156.2B |
| Long-Term Investments | -17.5B | -19.82B | -23.07B | -29.91B | -34.91B | -42.03B | 51.51B | 53.55B | 66B | 80.25B |
| Short-Term Investments | 17.5B | 19.82B | 23.07B | 29.91B | 34.91B | 42.03B | 44.82B | 49.51B | 62.17B | 75.95B |
| Total Current Assets | 21.92B | 24.71B | 28.96B | 36.78B | 46.65B | 54.65B | 59.84B | 66.26B | 79.56B | 23.32B |
| Cash & Equivalents | 224.1M | 211.5M | 265M | 69.5M | 226.2M | 76.5M | 187.1M | 203.5M | 85M | 143M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -72.25B |
| Goodwill & Intangibles | 942.5M | 882.2M | 819.3M | 747.3M | 681M | 624.1M | 570M | 314.2M | 1.92B | 2.19B |
| Goodwill | 447.6M | 449.4M | 452.7M | 452.7M | 452.7M | 452.7M | 452.7M | 227.9M | 228M | 228M |
| Intangible Assets | 494.9M | 432.8M | 366.6M | 294.6M | 228.3M | 171.4M | 117.3M | 86.3M | 1.69B | 1.96B |
| PP&E (Net) | 1.04B | 1.18B | 1.12B | 1.13B | 1.21B | 1.11B | 1.14B | 1.03B | 881M | 790M |
| Other Assets | 23.43B | 26.48B | 30.87B | 37.78B | 41.28B | 49.74B | -41.93B | -45.69B | -59.66B | -804M |
| Total Liabilities | 22.53B | 25.47B | 29.42B | 35.75B | 41.24B | 47.06B | 52.9B | 59.57B | 68.41B | 80.15B |
| Total Debt | 2.71B | 3.15B | 3.31B | 4.4B | 4.91B | 5.4B | 4.9B | 6.39B | 6.89B | 6.89B |
| Net Debt | 2.48B | 2.94B | 3.04B | 4.34B | 4.68B | 5.32B | 4.71B | 6.18B | 6.8B | 6.75B |
| Long-Term Debt | 2.71B | 3.15B | 37.1M | 3.91B | 4.41B | 5.4B | 4.9B | 6.39B | 6.89B | 6.89B |
| Short-Term Debt | 0 | 0 | 3.27B | 499.1M | 499.4M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 2.07B | 2.5B | 6.75B | 5.55B | 5.12B | 4.96B | 6.07B | 5.53B | 0 | 0 |
| Accounts Payable | 2.07B | 2.5B | 3.48B | 5.05B | 4.62B | 4.96B | 6.07B | 5.53B | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 1000K | 1000K | 1000K | 0 | 1000K | 1000K | 1000K | 0 | 0 | 0 |
| Other Liabilities | 17.64B | 19.72B | 22.49B | 26.3B | 31.6B | 36.4B | 41.78B | 47.65B | 61.52B | 73.26B |
| Total Equity | 7.29B | 7.96B | 9.28B | 10.82B | 13.67B | 17.04B | 18.23B | 15.89B | 20.28B | 25.59B |
| Equity Growth % | 0.05% | 0.09% | 0.17% | 0.17% | 0.26% | 0.25% | 0.07% | -0.13% | 0.28% | 0.26% |
| Shareholders Equity | 7.29B | 7.96B | 9.28B | 10.82B | 13.67B | 17.04B | 18.23B | 15.89B | 20.28B | 25.59B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 4.69B | 5.14B | 6.03B | 8.39B | 10.68B | 13.35B | 15.34B | 15.72B | 18.8B | 24.28B |
| Common Stock | 583.6M | 579.9M | 581.7M | 583.2M | 584.6M | 585.2M | 584.4M | 584.9M | 585M | 586M |
| Accumulated OCI | 800.4M | 933.4M | 1.28B | -120.9M | 341.7M | 931.7M | 40.7M | -2.8B | -1.62B | -1.42B |
| Return on Equity (ROE) | 0.18% | 0.14% | 0.18% | 0.26% | 0.32% | 0.37% | 0.19% | 0.04% | 0.22% | 0.37% |
| Return on Assets (ROA) | 0.05% | 0.03% | 0.04% | 0.06% | 0.08% | 0.1% | 0.05% | 0.01% | 0.05% | 0.09% |
| Equity / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / Equity | 0.37x | 0.40x | 0.36x | 0.41x | 0.36x | 0.32x | 0.27x | 0.40x | 0.34x | 0.27x |
| Book Value per Share | 12.37 | 13.60 | 15.85 | 18.45 | 23.29 | 29.00 | 31.05 | 27.07 | 34.51 | 43.54 |
| Tangible BV per Share | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 2.29B | 2.7B | 3.76B | 6.28B | 6.26B | 6.91B | 7.76B | 6.85B | 10.64B | 15.12B |
| Operating CF Growth % | 0.33% | 0.18% | 0.39% | 0.67% | -0% | 0.1% | 0.12% | -0.12% | 0.55% | 0.42% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 1.3B | 1.06B | 1.6B | 2.62B | 3.98B | 5.7B | 3.35B | 721.5M | 3.9B | 8.48B |
| Depreciation & Amortization | 150.5M | 199.5M | 236.1M | 262.4M | 306.1M | 331.8M | 337.4M | 336.6M | 299.7M | 284M |
| Stock-Based Compensation | 66.2M | 85.2M | 95.4M | 77.2M | 90.2M | 89.4M | 100.7M | 122.7M | 121.3M | 122M |
| Deferred Taxes | -12.3M | 37.2M | 43.8M | -5.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 900K | -1.6M | 1M | 477.6M | -984.9M | -1.52B | -1.38B | 2.11B | -275.5M | -281M |
| Working Capital Changes | 787.1M | 1.32B | 1.78B | 2.85B | 2.87B | 2.3B | 5.36B | 3.56B | 6.6B | 6.51B |
| Cash from Investing | -1.92B | -2.46B | -3.41B | -7.33B | -4.34B | -6.12B | -3.12B | -7.96B | -10.84B | -13.75B |
| Capital Expenditures | -130.7M | -215M | -155.7M | -266M | -363.5M | -223.5M | -243.5M | -292M | -252M | -285M |
| Acquisitions | -765.3M | 6.2M | -18.1M | -296.9M | 53.3M | 21.9M | -313.2M | 35.1M | 0 | 0 |
| Purchase of Investments | -9.96B | -12.04B | -14.84B | -21.69B | -29.15B | -36.38B | -34.02B | -28.54B | -25.86B | -47.95B |
| Sale/Maturity of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Investing | 2.4M | 59.4M | -18.3M | 21.1M | 6M | 83.6M | 114.1M | -177.8M | 36M | 248M |
| Cash from Financing | -252.8M | -250.4M | -300.9M | 549.8M | -1.77B | -938.8M | -4.52B | 1.13B | 78M | -1.32B |
| Dividends Paid | -403.6M | -519M | -395.4M | -668.4M | -1.67B | -1.58B | -3.77B | -260.8M | -277.6M | -682M |
| Share Repurchases | -208.5M | -192.5M | -62.5M | -79M | -91.3M | -111.6M | -223M | -99M | -140.7M | -634M |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 500M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | -1000K | 1000K | 1000K | 0 |
| Other Financing | 17M | 9.2M | 500K | -293.6M | -9.6M | -235.7M | 0 | 0 | 0 | 0 |
| Net Change in Cash | 116M | -12.6M | 48.9M | -200.3M | 152.4M | -150.9M | 125.6M | 18.8M | -121.3M | 54M |
| Exchange Rate Effect | -200K | 400K | -300K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 108.4M | 224.1M | 226.4M | 275.3M | 75M | 227.4M | 76.5M | 202.1M | 220.9M | 100M |
| Cash at End | 224.4M | 211.5M | 275.3M | 75M | 227.4M | 76.5M | 202.1M | 220.9M | 99.6M | 154M |
| Free Cash Flow | 2.16B | 2.49B | 3.6B | 6.02B | 5.9B | 6.68B | 7.52B | 6.56B | 10.39B | 14.83B |
| FCF Growth % | 0.34% | 0.15% | 0.45% | 0.67% | -0.02% | 0.13% | 0.13% | -0.13% | 0.58% | 0.43% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF per Share | 3.67 | 4.25 | 6.15 | 10.26 | 10.04 | 11.37 | 12.81 | 11.17 | 17.69 | 25.24 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 90.82% | 93.72% | 92.02% | 90.1% | 86.77% | 83.18% | 91.17% | 98.14% | 92.1% | 85.78% |
| Medical Cost Ratio | 76.78% | 80.04% | 78.06% | 76.03% | 73.07% | 66.6% | 78.32% | 84.78% | 81.05% | 72.26% |
| Return on Equity (ROE) | 17.83% | 13.52% | 18.47% | 26.01% | 32.42% | 37.15% | 19% | 4.23% | 21.58% | 36.98% |
| Return on Assets (ROA) | 4.56% | 3.26% | 4.41% | 6.13% | 7.82% | 9.59% | 4.96% | 0.98% | 4.76% | 8.72% |
| Equity / Assets | 24.45% | 23.8% | 23.99% | 23.24% | 24.9% | 26.58% | 25.63% | 21.06% | 22.86% | 24.2% |
| Book Value / Share | 12.37 | 13.6 | 15.85 | 18.45 | 23.29 | 29 | 31.05 | 27.07 | 34.51 | 43.54 |
| Debt / Equity | 0.37x | 0.40x | 0.36x | 0.41x | 0.36x | 0.32x | 0.27x | 0.40x | 0.34x | 0.27x |
| Revenue Growth | 7.51% | 12.41% | 14.51% | 19.16% | 22.04% | 9.33% | 11.82% | 4.01% | 25.2% | 21.36% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Personal Lines | - | 19.19B | 21.95B | 26.03B | 30.21B | 32.62B | - | 37.88B | 46.21B | 60.98B |
| Personal Lines Growth | - | - | 14.38% | 18.62% | 16.04% | 7.98% | - | - | 22.00% | 31.96% |
| Commercial Lines | - | 2.42B | 2.79B | 3.61B | 4.43B | 4.88B | - | 9.09B | 9.9B | 10.88B |
| Commercial Lines Growth | - | - | 15.39% | 29.24% | 22.62% | 10.12% | - | - | 8.92% | 9.89% |
| Property | - | 864.5M | 988.8M | 1.29B | 1.55B | 1.77B | - | 2.27B | 2.55B | - |
| Property Growth | - | - | 14.38% | 30.23% | 20.74% | 13.56% | - | - | 12.40% | - |
| Direct Channel | - | - | - | - | - | - | 18.49B | - | - | - |
| Direct Channel Growth | - | - | - | - | - | - | - | - | - | - |
| Agency Channel | - | - | - | - | - | - | 16.88B | - | - | - |
| Agency Channel Growth | - | - | - | - | - | - | - | - | - | - |
| Property and Casualty, Commercial Insurance Product Line | 2B | - | - | - | - | - | - | - | - | - |
| Property and Casualty, Commercial Insurance Product Line Growth | - | - | - | - | - | - | - | - | - | - |
| Property, Liability and Casualty Insurance Product Line | 609.1M | - | - | - | - | - | - | - | - | - |
| Property, Liability and Casualty Insurance Product Line Growth | - | - | - | - | - | - | - | - | - | - |
| Other Indemnity | 400K | - | - | - | - | - | - | - | - | - |
| Other Indemnity Growth | - | - | - | - | - | - | - | - | - | - |
The Progressive Corporation (PGR) has a price-to-earnings (P/E) ratio of 14.1x. This may indicate the stock is undervalued or faces growth challenges.
The Progressive Corporation (PGR) grew revenue by 21.4% over the past year. This is strong growth.
Yes, The Progressive Corporation (PGR) is profitable, generating $10.43B in net income for fiscal year 2024 (11.3% net margin).
Yes, The Progressive Corporation (PGR) pays a dividend with a yield of 0.56%. This makes it attractive for income-focused investors.
The Progressive Corporation (PGR) has a return on equity (ROE) of 37.0%. This is excellent, indicating efficient use of shareholder capital.
The Progressive Corporation (PGR) has a combined ratio of 85.8%. A ratio below 100% indicates underwriting profitability.